Tumor-specific Nano-entities for Optical Detection and Hyperthermic Treatment of Breast Cancer
Purchase on Springer.com
$29.95 / €24.95 / £19.95*
* Final gross prices may vary according to local VAT.
The ultimate goal of this study is to develop a tumor-specific multi-functional, nano-entity that can be used for both cancer detection and treatment. Low heat (42~45°C) hyperthermia is an effective cancer treatment method with little side effect. Magnetic nanoparticles, such as Fe3O4, can be heated by alternating electromagnetic (AEM) fields at well selected frequencies, without heating normal tissue. Nanogold particles (NGPs) are effective optical absorbers and also excellent fluorescent enhancers. Therefore, coating gold on Fe3O4 particles can enhance the optical contrast as well as keeping the particle property for hyperthermia. Indocyanine green (ICG), a FDA approved fluorophore, has a very low quantum yield, and its fluorescence can be enhanced by linking ICGto gold-coated Fe3O4 nanoparticles. Luteinizing hormone releasing hormone (LHRH), which has high affinity to breast cancer, can be used for tumor-specific targeting. Our study results showed: Fe3O4 particles at a size range of 10~30 nm can be heated well by an AEM field at a rate of 18°C/wt%-minute; the fluorescence of ICG was extensively enhanced by NGPs; LHRH-coated gold nanoparticles provided as much cancer specificity as LHRHalone. Combining these properties in one entity, i.e.,LHRH/ICGlinked, gold-coated Fe3O4 nanoparticles, can be a tumor-specific nano-agent for optical detection and electro-magnetically induced hyperthermia for breast cancer.
- F. Kristian Storm, Hyperthermia in Cancer Therapy, (G. K. Hall Medical Publishers, Boston, MA, 1983).
- S. Sharma, S.P. Sandhu, F. D. Patel, S. Ghoshal, B. D. Gupta, and N. S. Yadav, Cervix cancer and hyperthermia: Side-effects of local hyperthermia: results of a prospectively randomized clinical study, Int. J. Hyperthermia, 6 (2), 279–285, (1990). CrossRef
- T. Ohtsubo, H. Igawa, T. Saito, H. matsumoto, H. Park, C. W. Song, E. Kano, and H. Saito, Enhancement of cell killing by induction of apoptosis after treatment with mild hyperthermia at 42°C and cisplatin, Radiation Research, 156, 103–109, (2001). CrossRef
- A. Jordan, R. Scholz, P. Wust, H. Fahling, and R. Felix, Magnetic fluid hyperthermia (MFH): cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles J. Magn. Magn. Mater. 201, 413–419, (1999). CrossRef
- P. Tartaj, M.P. Morales, S. Veintemillas-Verdaguer, T. Gonz'alez-Carreno, and C.J. Serna, The preparation of magnetic nanoparticles for applications in biomedicine, J. Phys. D: Appl. Phys. 36, R182–197, (2003). CrossRef
- D. Bahadur, and J. Giri, Biomaterials and magnetism, Sadhana, 28 (3 and 4), 639–656, (2003). CrossRef
- S. Mornet, S. Vasseur, F. Grasset, and E. Duguet, Magnetic nanoparticle design for medical diagnosis and therapy, J. Mater. Chem., 14, 2161–2175, (2004). CrossRef
- S. J. Oldenburg, J. B. Jackson, S. L. Westcott, and N. J. Halas, Infrared extinction properties of gold nanoshells, Applied Physics Letters, 78 (19), 2897–2899, (1999). CrossRef
- C. H. Chou, C. D. Chen, and C. R. Wang, Highly Efficient, Wavelength-Tunable, Gold Nanoparticle Based photothermal Nanoconvertors, J. Phys. Chem. B, 109, 11135–11138, (2005). CrossRef
- S. Achilefu, R. B. Dorshow, J. E. Bugaj, and R. Rajagopalan, Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging. Invest Radiol, 35:479–485, (2000). CrossRef
- C. D. Geddes, A. Parfenov, D. Roll, M. J. Uddin, and J. R. Lakowicz, Fluorescence spectral properties of indocyanine green on a roughened platinum electrode: Metal-enhanced fluorescence, Journal of Fluorescence, 13 (6), 453–457, (2003). CrossRef
- B. Hong and K.A. Kang, Biocompatible, nanogold-particle fluorescence enhancer for fluorophore mediated, optical immunosensor, Biosensors and Bioelectronics, 21(7), 1333–1338, (2006). CrossRef
- R. Eckert, D. Randall, and G. Augustin, Animal Physiology, 3rd Edition, W. H. Freeman and Company, New York, 435–473, (1988).
- S. S. Kakar, L. C. Musgrove, D. C. Devor, J. C. Sellers, and J. D. Neill, Cloning, sequencing, and expression of human gonadotropin releasing hormone (GnRH) receptor. Biochem. Biophys. Res. Commun. 189, 289–295, (1992). CrossRef
- M. Preuss, W.G. Schmidt, and F. Bechstedt, Coulombic amino group-metal bonding: Adsorption of adenine on Cu (110), Physical Review Letters, 94, 236102–4, (2005). CrossRef
- S. S. Kakar, W. E. Grizzle, and J. D. Neill, The nucleotide sequences of human GnRH receptors in breast and ovarian tumors are identical with that found in pituitary, Mol. Cell. Endocrinol. 106, 145–149, (1994). CrossRef
- S. S. Kakar, M. T. Malik, S. J. Winters, and W. Mazhawidza, Gonadotropin-releasing hormone receptors: structure, expression, and signaling transduction. Vitam Horm. 69, 151–207, (2004).
- H. Jin and K. A. Kang, Fluorescent mediated detection of Heterogeneity in a highly scattering media, Adv. Exper. Med. Bio., 566, 167–172, (2005). CrossRef
- T. L. Troy, B. W. Pogue, E. D. Genety, S. B. Poplack, O. L. Osterburg, and K. D. Paulsen, Spectroscopic diffuse optical tomography for the quantitative assessments of hemoglobin concentration and oxygen saturation in human breast tissue, Appl. Opt., 38(25), 5480–5490, (1999).
- A.L. Honar and K.A. Kang, Effect of the source and detector configuration on the detectability of breast cancer, Comp. Biochem.Physio - Part A: Molecular & Integrative Physiology, 132(1), 9–15, (2002). CrossRef
- D. F. Bruley, Pulse reduction code written for process identification (personal communication), (1974).
- S. S. Kakar, S. J., Winters, W. Zacharias, D. M. Miller, and S. Flynn, Identification of distinct gene expression profiles associated with treatment of LbetaT2 cells with gonadotropin-releasing hormone agonist using microarray analysis. Gene. 308, 67–77, (2003). CrossRef
- H. Jin and K. A. Kang, Application of Novel Metal Nanoparticles as Optical/Thermal Agents in Optical Mammography and Hyperthermic Treatment for Breast Cancer, Proceedings of the 33rd ISOTT Annual Meeting, August 28-September 2, Brisbane, Australia, Manuscript Submitted, (2005).
- Tumor-specific Nano-entities for Optical Detection and Hyperthermic Treatment of Breast Cancer
- Book Title
- Oxygen Transport to Tissue XXIX
- Book Part
- Part VII
- pp 275-284
- Print ISBN
- Online ISBN
- Series Title
- Advances In Experimental Medicine And Biology
- Series Volume
- Series ISSN
- Springer US
- Copyright Holder
- Springer Science+Business Media, LLC
- Additional Links
- Industry Sectors
- eBook Packages
- Editor Affiliations
- 6. Department of Chemical Engineering, University of Louisville
- 7. Durham Unit Regional Medical Physics Department, University Hospital of North Durham
- 8. Synthesizer Inc
- 9. UMBC
- Author Affiliations
- 10. Department of Chemical Engineering, Department of Medicine, University of Louisville, Louisville, KY 40292, USA
- 11. Department of Medicine, University of Louisville, Louisville, KY 40292
To view the rest of this content please follow the download PDF link above.